Hematology:Multiples myeloma — Chemotherapy and radiation therapy. Treatment abroad
The use of new chemotherapeutic drugs and radiotherapy in the treatment of multiple myeloma allows increasing the life expectancy of patients three times. Undoubtedly, the treatment effectiveness is higher when the diagnosis is established and an adequate treatment is started earlier, but in the case of widespread metastasis, the skilled European clinics manage to achieve positive results.
After the first visit to the clinic and case history collection, the patient undergoes a general clinical and special examination, which includes:
- complete blood count and urinalysis;
- blood chemistry;
- immunological investigation;
- CT and MRI visualize the pathological foci;
- bone marrow biopsy subject to microscopic examination of the obtained material.
The protocol of chemotherapy and radiation therapy is based on the findings of a comprehensive survey.
Prescription of drugs inhibiting the growth and spread of the tumor tissue, in many cases, allows achieving the remission of varying length. Thalidomide, melphalan, lenalidomide, bortezomib and other active drugs are prescribed for treatment of multiple myeloma. To enhance the chemotherapy effect, the patients are often prescribed hormonal drugs supporting the function of vital organs and preventing complications.
Chemotherapy treatment is selected in the hospital where the patient is observed by the physician and enjoys services of the nursing staff in the required volume. The cost of drugs depends on the treatment protocol and clinics.
Radiation therapy for multiple myeloma is a complementary method. It is used in conjunction with chemotherapy or as a palliative agent to improve the patient’s condition. After treatment, the patient receives recommendations for monitoring and further treatment.Hide